Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.81B |
| 2 |
Microsoft
MSFT
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$204M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.47% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Astec Industries
ASTE
$1.02B
| $22.8M | ﹤0.01% |
520,835
+10,045
| +2% | +$375K |
|
|
MODN
1852
DELISTED
MODEL N, INC.
MODN
| $22.8M | ﹤0.01% |
799,036
+31,281
| +4% | +$826K |
|
|
DAWN
1853
DELISTED
Day One Biopharmaceuticals
DAWN
| $22.8M | ﹤0.01% |
1,376,961
+28,142
| +2% | +$421K |
|
1854
Claros Mortgage Trust
CMTG
$274M
| $22.7M | ﹤0.01% |
2,328,207
+51,595
| +2% | +$559K |
|
1855
Central Garden & Pet Co
CENT
$2.8B
| $22.7M | ﹤0.01% |
529,152
-97,369
| -16% | -$3.97M |
|
1856
Ocular Therapeutix
OCUL
$2.02B
| $22.6M | ﹤0.01% |
2,486,043
+749,229
| +43% | +$5.32M |
|
1857
Dream Finders Homes
DFH
$1.36B
| $22.6M | ﹤0.01% |
516,922
+18,081
| +4% | +$637K |
|
1858
Under Armour
UAA
$2.6B
| $22.6M | ﹤0.01% |
3,062,534
+115,576
| +4% | +$920K |
|
1859
PubMatic
PUBM
$810M
| $22.5M | ﹤0.01% |
946,412
+16,370
| +2% | +$293K |
|
|
SP
1860
DELISTED
SP Plus Corporation
SP
| $22.4M | ﹤0.01% |
429,835
+9,594
| +2% | +$495K |
|
1861
OceanFirst Financial
OCFC
$1.91B
| $22.4M | ﹤0.01% |
1,362,893
+31,982
| +2% | +$516K |
|
1862
SiriusPoint
SPNT
$2.68B
| $22.4M | ﹤0.01% |
1,759,490
-27,541
| -2% | -$328K |
|
1863
BioCryst Pharmaceuticals
BCRX
$2.4B
| $22.4M | ﹤0.01% |
4,400,271
+139,633
| +3% | +$785K |
|
1864
AvePoint
AVPT
$2.71B
| $22.3M | ﹤0.01% |
2,820,404
+67,264
| +2% | +$529K |
|
|
SAGE
1865
DELISTED
Sage Therapeutics
SAGE
| $22.3M | ﹤0.01% |
1,191,331
+24,074
| +2% | +$555K |
|
|
CIM
1866
Chimera Investment
CIM
$1B
| $22.3M | ﹤0.01% |
1,610,037
-11,358
| -0.7% | -$158K |
|
|
PYCR
1867
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $22.2M | ﹤0.01% |
1,144,158
+37,024
| +3% | +$740K |
|
1868
BCE
BCE
$21.2B
| $22.2M | ﹤0.01% |
581,342
+113,185
| +24% | +$4.31M |
|
1869
Under Armour Class C
UA
$2.53B
| $22.2M | ﹤0.01% |
3,102,036
+96,879
| +3% | +$742K |
|
1870
CG Oncology
CGON
$6.66B
| $22.1M | ﹤0.01% |
+504,216
| New | +$20.6M |
|
1871
Arcus Biosciences
RCUS
$3.64B
| $22.1M | ﹤0.01% |
1,171,968
+29,799
| +3% | +$515K |
|
1872
Mativ Holdings
MATV
$711M
| $22.1M | ﹤0.01% |
1,176,778
+13,512
| +1% | +$202K |
|
1873
Malibu Boats
MBUU
$567M
| $21.9M | ﹤0.01% |
506,191
+15,902
| +3% | +$729K |
|
|
NKLA
1874
DELISTED
Nikola Corporation Common Stock
NKLA
| $21.9M | ﹤0.01% |
701,920
+114,323
| +19% | +$2.45M |
|
1875
Levi Strauss
LEVI
$9.39B
| $21.8M | ﹤0.01% |
1,089,885
+57,159
| +6% | +$993K |
|
Similar funds
Geode Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.
- Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
- Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
- Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
- Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
- Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
- Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.